PFKFB3 and hepatocellular carcinoma: In addition, aspirin has been reported to overcome sorafenib resistance in hepatocellular carcinoma by blocking PFKFB3 (Li et al., 2017), and inhibition of PFKFB3 also reduces DNA repair to control the growth of hepatocellular carcinoma (Shi et al., 2018).